CIB4 Antibody

What is CIB4 and why is it important in biological research?

CIB4 (calcium and integrin binding family member 4), also known as KIP4, is a member of the calcium and integrin binding protein family. This protein has gained significant research interest due to its strong expression in testicular tissue and crucial role in spermatogenesis. Studies with knockout (KO) mice have demonstrated that CIB4 is essential for the haploid phase of spermatogenesis, making it particularly important for reproductive biology research . CIB4 is related to CIB1, a ubiquitously expressed protein with three paralogs (CIB2, CIB3, and CIB4). Research has shown that CIB1 KO male mice are sterile due to impaired haploid differentiation, suggesting functional relationships between CIB family members in reproductive processes .

What are the common applications for CIB4 antibodies in research?

CIB4 antibodies are versatile research tools validated for multiple experimental applications:

These applications enable researchers to investigate CIB4 expression, localization, and function across different biological contexts and experimental systems .

What species reactivity should I consider when selecting a CIB4 antibody?

When selecting a CIB4 antibody, species reactivity is a critical consideration for experimental design. Most commercially available CIB4 antibodies are raised in rabbits (rabbit polyclonal) and show reactivity with human and mouse samples . Some antibodies also cross-react with rat and bovine samples . The confirmed reactivity pattern varies between products, so researchers should verify the specific reactivity profile of their chosen antibody before designing experiments.

For example:

• The antibody from Novatein Biosciences (Cat# SH-A11088) shows reactivity with human and mouse samples

• Proteintech's antibody (18840-1-AP) has been validated for human and mouse samples

• Some MyBioSource antibodies show broader reactivity including human, mouse, rat, and bovine samples

Always check the manufacturer's validation data for your specific research model to ensure compatibility.

What is the recommended protocol for using CIB4 antibodies in Western blot experiments?

For optimal Western blot results with CIB4 antibodies, follow this general protocol with appropriate modifications based on your specific antibody:

• Sample Preparation: Extract proteins from your biological sample using appropriate lysis buffer.

• Protein Quantification: Determine protein concentration using Bradford or BCA assay.

• SDS-PAGE: Load 20-40 μg of protein per lane and separate by electrophoresis.

• Transfer: Transfer proteins to a PVDF or nitrocellulose membrane.

• Blocking: Block the membrane with 5% non-fat milk or BSA in TBST for 1-2 hours at room temperature.

• Primary Antibody Incubation: Dilute CIB4 antibody at 1:500-1:1000 in blocking buffer and incubate overnight at 4°C .

• Washing: Wash membrane 3-5 times with TBST.

• Secondary Antibody: Incubate with appropriate HRP-conjugated secondary antibody (typically anti-rabbit IgG) at 1:5000-1:10000 dilution.

• Detection: Develop using ECL substrate and image.

The expected molecular weight of CIB4 is approximately 22 kDa, which corresponds to the observed molecular weight in validated Western blots . Mouse lung tissue has been confirmed as a positive control for CIB4 detection .

How should I optimize antigen retrieval methods for CIB4 immunohistochemistry in different tissue types?

Antigen retrieval optimization is critical for successful CIB4 immunohistochemistry, as improper retrieval can lead to false negative results or increased background. Based on published protocols, consider the following approach:

The primary recommendation for CIB4 antibodies is antigen retrieval with TE buffer pH 9.0 . Alternatively, citrate buffer pH 6.0 can be used, though it may yield different staining intensity . When working with tissues beyond the validated examples (such as human kidney tissue), optimization becomes necessary.

For optimization:

• Buffer comparison: Test both TE buffer (pH 9.0) and citrate buffer (pH 6.0) in parallel.

• Time variation: Test different retrieval durations (10, 20, and 30 minutes).

• Temperature assessment: Compare heat-mediated retrieval methods (microwave, pressure cooker, or water bath).

• Tissue-specific modifications: Different fixation times may require adjustment of retrieval conditions.

• Antibody titration: After determining optimal retrieval conditions, titrate antibody dilutions (starting with 1:20, 1:50, 1:100, and 1:200) .

For reproducible results, maintain consistent fixation time across experimental samples and include positive controls (like human kidney tissue) in each batch.

What are the considerations for investigating CIB4 expression during spermatogenesis using immunohistochemical approaches?

Investigating CIB4 expression during spermatogenesis requires thoughtful experimental design due to the stage-specific expression patterns during this complex developmental process:

• Developmental staging: CIB4 begins expression during the haploid phase of spermatogenesis in mice . Therefore, accurate staging of seminiferous tubules is essential for proper interpretation of results.

• Comparison with CIB1: Given the relationship between CIB4 and CIB1 in spermatogenesis, parallel staining for both proteins may provide valuable insights into their coordinated functions.

• Cross-species comparisons: CIB4 is strongly expressed in both mouse and human testis , making comparative studies possible, though species-specific optimization is necessary.

• Technical considerations:

  • Use thin sections (4-5 μm) for optimal antibody penetration

  • Include counterstaining to identify specific cell types within the seminiferous epithelium

  • Consider dual immunofluorescence with markers of specific spermatogenic stages

  • Use confocal microscopy for precise subcellular localization

• Controls: Include both positive controls (known CIB4-expressing tissues) and negative controls (CIB4 knockout tissue if available, or primary antibody omission) in each experiment.

This approach will help distinguish CIB4 expression patterns throughout the complex cellular transitions of spermatogenesis while minimizing technical artifacts.

How can I validate CIB4 antibody specificity to ensure reliable experimental results?

Validating antibody specificity is crucial for obtaining reliable research results and avoiding misinterpretation of data. For CIB4 antibodies, consider this comprehensive validation strategy:

• Western blot analysis:

  • Verify detection of a single band at the expected molecular weight (22 kDa)

  • Test in tissues known to express CIB4 (mouse lung, testis) and those with low expression

  • Include positive and negative control lysates

• Genetic validation:

  • Use CIB4 knockout tissue/cells as the gold standard negative control when available

  • Alternatively, use CIB4 siRNA/shRNA knockdown cells

  • Compare results with overexpression systems

• Peptide competition assay:

  • Pre-incubate the antibody with the immunizing peptide or recombinant CIB4 protein

  • Observe elimination or reduction of specific signal

• Orthogonal validation:

  • Compare results from two different CIB4 antibodies targeting distinct epitopes

  • Correlate protein detection with mRNA expression data (RT-PCR, RNA-seq)

• Application-specific validation:

  • For IHC: Compare staining patterns across multiple antibodies and with mRNA localization

  • For WB: Verify molecular weight and band pattern across different tissue types

• Cross-reactivity assessment:

  • Test for potential cross-reactivity with other CIB family members (CIB1, CIB2, CIB3)

  • Use recombinant proteins or overexpression systems for each family member

A blocking peptide is available for some CIB4 antibodies, which can serve as an excellent tool for specificity validation .

What approaches can be used to investigate the functional relationship between CIB4 and other CIB family members in reproductive biology?

Investigating functional relationships between CIB4 and other family members requires multiple complementary approaches:

• Expression profiling:

  • Compare spatiotemporal expression patterns of all CIB family members (CIB1, CIB2, CIB3, CIB4) in reproductive tissues

  • Use quantitative PCR, Western blot, and immunohistochemistry with validated antibodies for each family member

  • Analyze single-cell RNA sequencing data to identify co-expression patterns in specific cell types

• Protein-protein interaction studies:

  • Co-immunoprecipitation to detect direct interactions between CIB family members

  • Proximity ligation assay (PLA) to visualize protein interactions in situ

  • FRET/BRET assays for live-cell interaction analysis

• Genetic approaches:

  • Compare phenotypes of individual and combined CIB family knockout models

  • Generate conditional knockout mouse models to examine tissue-specific requirements

  • Use CRISPR/Cas9-mediated gene editing to introduce specific mutations

• Calcium signaling analysis:

  • Since CIB proteins bind calcium, examine calcium dynamics in reproductive cells from wildtype and CIB4 knockout mice

  • Investigate whether calcium responses are altered in the absence of CIB4

  • Determine if other CIB proteins compensate for CIB4 loss

• Integrin signaling investigation:

  • Analyze integrin-dependent processes in reproductive tissues of CIB4 knockout models

  • Examine downstream signaling pathways using phosphorylation-specific antibodies

  • Assess cell adhesion and migration in the presence and absence of CIB4

Research has established that CIB1 knockout male mice are sterile due to impaired haploid differentiation, while CIB4 is essential for the haploid phase of spermatogenesis . These findings suggest potential functional redundancy or cooperation that merits systematic investigation.

What are the optimal storage and handling conditions to maintain CIB4 antibody performance?

Proper storage and handling of CIB4 antibodies is essential for maintaining their performance over time. Follow these guidelines based on manufacturer recommendations:

• Storage temperature:

  • Store antibodies at -20°C for long-term storage

  • Avoid repeated freeze-thaw cycles by preparing single-use aliquots

• Buffer conditions:

  • Most CIB4 antibodies are provided in PBS with 0.02-0.1% sodium azide and 50% glycerol at pH 7.3

  • This formulation provides stability during frozen storage

• Aliquoting procedure:

  • Thaw original vial on ice

  • Prepare appropriate volumes based on typical experiment needs

  • Use sterile microcentrifuge tubes

  • Return to -20°C immediately after aliquoting

• Working solution handling:

  • Keep antibody on ice during experiment preparation

  • Return to 4°C for short-term storage (1-2 weeks)

  • Avoid prolonged exposure to room temperature

• Stability information:

  • When properly stored, CIB4 antibodies remain stable for at least one year after shipment

  • Monitor performance over time using consistent positive controls

• Contamination prevention:

  • Use clean pipette tips for each handling

  • Avoid introducing foreign material into antibody solutions

  • Consider adding additional preservative for diluted working stocks

Following these practices will help ensure consistent antibody performance across multiple experiments over time.

How should I determine the optimal antibody concentration for new experimental conditions or tissue types?

When adapting CIB4 antibody protocols to new experimental conditions or tissue types, a systematic titration approach is essential:

• Starting point selection:

  • Begin with the manufacturer's recommended dilution range:

    • Western blot: 1:500-1:1000

    • Immunohistochemistry: 1:20-1:200

    • ELISA: 1:500-3000

• Gradient titration design:

  • For Western blot:

    • Test 3-4 dilutions spanning the recommended range (e.g., 1:250, 1:500, 1:1000, 1:2000)

    • Use a consistent protein amount across lanes

    • Include positive control tissue (mouse lung)

  • For immunohistochemistry:

    • Prepare serial dilutions (e.g., 1:20, 1:50, 1:100, 1:200, 1:500)

    • Use serial sections of the same tissue block

    • Include known positive tissue (human kidney)

• Evaluation criteria:

  • Signal-to-noise ratio: Measure specific signal strength versus background

  • Signal specificity: Confirm band size (22 kDa for CIB4) or expected cellular localization

  • Signal intensity: Quantify using densitometry or imaging software

• Optimization variables:

  • Incubation time: Test overnight at 4°C versus 1-3 hours at room temperature

  • Blocking conditions: Compare different blocking agents (milk, BSA, serum)

  • Detection system: Adjust secondary antibody concentration or detection reagents

• Documentation and standardization:

  • Record all parameters for reproducibility

  • Once optimal conditions are established, maintain consistency across experiments

  • Consider preparing a standard curve with recombinant protein if quantitative analysis is needed

This methodical approach will help identify conditions that maximize specific signal while minimizing background, enabling reliable detection of CIB4 across different experimental systems.

What troubleshooting approaches should I use when experiencing weak or absent CIB4 signal in Western blot or immunohistochemistry?

When encountering weak or absent CIB4 signal, implement this systematic troubleshooting framework:

For Western Blot Issues:

• Sample preparation:

  • Ensure complete protein extraction using appropriate lysis buffers

  • Add protease inhibitors to prevent degradation

  • Verify protein concentration and loading consistency

  • Consider using fresh tissue samples, as CIB4 may be unstable in long-term storage

• Transfer efficiency:

  • Verify transfer using reversible protein stain (Ponceau S)

  • Adjust transfer conditions for proteins in the 22 kDa range

  • Consider using PVDF membrane instead of nitrocellulose for better protein retention

• Antibody-specific adjustments:

  • Increase primary antibody concentration (try 1:250 if 1:500 fails)

  • Extend primary antibody incubation time to overnight at 4°C

  • Use mouse lung tissue as a positive control

  • Verify antibody viability with a dot blot of recombinant CIB4

• Detection system:

  • Use more sensitive ECL substrate for weakly expressed proteins

  • Increase exposure time during imaging

  • Try signal amplification systems (biotin-streptavidin)

For Immunohistochemistry Issues:

• Fixation and processing:

  • Excessive fixation may mask epitopes; adjust fixation time

  • Ensure proper tissue processing and embedding

  • Prepare fresh sections for staining

• Antigen retrieval optimization:

  • Compare TE buffer (pH 9.0) with citrate buffer (pH 6.0)

  • Extend retrieval time to 30 minutes

  • Try different heat sources (microwave, pressure cooker)

• Staining protocol adjustments:

  • Increase antibody concentration (start with 1:20 dilution)

  • Extend primary antibody incubation (overnight at 4°C)

  • Use polymer-based detection systems for signal amplification

  • Include human kidney tissue as a positive control

• Blocking and background:

  • Optimize blocking (try 5-10% normal serum from secondary antibody species)

  • Include protein blocking step to reduce non-specific binding

  • Add 0.1-0.3% Triton X-100 for better antibody penetration

If signal remains problematic after these adjustments, consider testing an alternative CIB4 antibody that targets a different epitope to address potential epitope masking or protein modification issues.

How can CIB4 antibodies be used to investigate male infertility mechanisms in research models?

CIB4 antibodies offer powerful tools for investigating male infertility mechanisms, particularly given the established role of CIB4 in spermatogenesis:

• Expression analysis in infertility models:

  • Compare CIB4 expression levels using Western blot and immunohistochemistry between fertile and infertile animal models

  • Quantify expression changes in different types of infertility (meiotic arrest, post-meiotic defects)

  • Correlate CIB4 expression patterns with specific stages of spermatogenic arrest

• Cellular and subcellular localization studies:

  • Use immunofluorescence with CIB4 antibodies to map protein distribution in testicular cells

  • Perform co-localization studies with markers of haploid spermatid development

  • Examine changes in CIB4 localization in response to hormonal or environmental stressors

• Mechanistic investigations:

  • Study how CIB4 knockout affects calcium signaling during spermatogenesis

  • Investigate potential integrin-binding functions in testicular cell adhesion

  • Examine relationships between CIB4 and known fertility factors

• Translational approaches:

  • Analyze CIB4 expression in testicular biopsies from infertile patients

  • Correlate expression levels with specific clinical diagnoses

  • Investigate potential biomarker applications for specific infertility subtypes

• Therapeutic target assessment:

  • Use CIB4 antibodies to monitor protein expression in response to hormonal therapies

  • Evaluate CIB4 as a potential target for male contraception research

  • Study recovery of CIB4 expression patterns following treatment interventions

Research has established that CIB4 is essential for the haploid phase of spermatogenesis in mice, and CIB4 knockout mice demonstrate fertility defects . This makes CIB4 a promising target for understanding specific mechanisms of male infertility, particularly those involving post-meiotic spermatid development.

What considerations should be made when designing multiplexed immunofluorescence experiments including CIB4 antibodies?

Designing successful multiplexed immunofluorescence experiments with CIB4 antibodies requires careful planning:

• Antibody compatibility assessment:

  • Select primary antibodies raised in different host species to avoid cross-reactivity

  • If using multiple rabbit antibodies (including CIB4), consider sequential staining with complete stripping between rounds

  • Validate each antibody individually before multiplexing

• Fluorophore selection:

  • Choose fluorophores with minimal spectral overlap

  • Consider signal strength compatibility (balance strong and weak signals)

  • For CIB4 detection, MaxLight 405 and MaxLight 550 conjugated antibodies are available options

• Antigen retrieval coordination:

  • Ensure all target antigens are retrievable under the same conditions

  • If CIB4 requires TE buffer pH 9.0 but other targets need different conditions, test compromise conditions

• Controls for multiplexed experiments:

  • Single-stain controls for each antibody

  • Fluorescence minus one (FMO) controls

  • Absorption controls using blocking peptides where available

• Technical considerations:

  • Minimize autofluorescence with appropriate quenching steps

  • Use spectral unmixing for closely overlapping fluorophores

  • Consider tyramide signal amplification for weak signals

• Analysis approach:

  • Plan quantification strategy before starting (colocalization, intensity ratios, etc.)

  • Consider computational approaches for analyzing complex staining patterns

  • Use consistent thresholding methods across experimental groups

When including CIB4 in multiplexed panels, particularly promising combinations include markers of calcium signaling pathways, integrin-associated proteins, and stage-specific markers of spermatogenesis given CIB4's established role in these contexts .

How can CIB4 antibodies be used in comparative studies across species to understand evolutionary conservation of CIB protein functions?

CIB4 antibodies provide valuable tools for evolutionary studies of calcium and integrin binding proteins across species:

• Cross-species reactivity assessment:

  • Many CIB4 antibodies show reactivity with multiple species including human, mouse, rat, and bovine samples

  • Begin by validating antibody performance in each target species using Western blot

  • Document epitope conservation through sequence alignment of immunogen regions

• Comparative expression analysis:

  • Map CIB4 expression patterns across homologous tissues in different species

  • Compare developmental timing of expression, particularly in reproductive tissues

  • Quantify relative expression levels using calibrated Western blot approaches

• Functional domain conservation studies:

  • Use domain-specific antibodies to examine conservation of key functional regions

  • Compare post-translational modifications across species

  • Investigate protein-protein interactions in different species using co-immunoprecipitation

• Evolutionary context integration:

  • Correlate protein expression patterns with phylogenetic relationships

  • Connect functional differences to adaptive evolutionary changes

  • Compare CIB4 with other CIB family members to understand paralog divergence

• Methodological considerations:

  • Standardize tissue collection and processing across species

  • Adjust antibody concentrations for each species based on empirical testing

  • Include appropriate positive and negative controls for each species

This approach is particularly valuable for reproductive biology research, as CIB4 shows strong expression in both mouse and human testis , suggesting evolutionary conservation of function in mammalian reproduction that could extend to other species.

What experimental approaches can help distinguish between the functions of different CIB family members in biological systems?

Distinguishing between functions of CIB family members requires multifaceted experimental approaches:

• Specific antibody validation:

  • Conduct cross-reactivity testing against all CIB family proteins

  • Use recombinant proteins for each family member to confirm specificity

  • Develop validation protocols using knockout or knockdown systems

• Comparative expression mapping:

  • Create comprehensive expression atlases for all CIB proteins (CIB1-4)

  • Use validated antibodies for each family member in parallel experiments

  • Document cell type-specific and subcellular distribution patterns

• Loss-of-function studies:

  • Compare phenotypes of individual CIB family knockouts

  • Generate conditional and inducible knockout models

  • Create combination knockouts to identify redundant functions

  • Use siRNA/shRNA for acute depletion studies

• Domain-specific functional analysis:

  • Create domain-swap chimeras between CIB family members

  • Use domain-specific antibodies to track modified proteins

  • Analyze calcium-binding and integrin-binding properties of each family member

• Interaction partner identification:

  • Perform immunoprecipitation with specific antibodies followed by mass spectrometry

  • Use proximity labeling approaches (BioID, APEX) to identify neighborhood proteins

  • Validate interactions with co-immunoprecipitation and proximity ligation assays

• Functional rescue experiments:

  • Express different CIB family members in CIB4-deficient systems

  • Quantify degree of functional rescue

  • Identify domains responsible for shared versus unique functions

These approaches become particularly important in reproductive biology research where CIB1 and CIB4 both play essential roles in spermatogenesis but potentially through different mechanisms .

What emerging technologies might enhance the utility of CIB4 antibodies in single-cell analysis of reproductive tissues?

Emerging technologies are expanding the potential applications of CIB4 antibodies for single-cell analysis in reproductive research:

• Mass cytometry (CyTOF) integration:

  • Metal-conjugated CIB4 antibodies can be incorporated into CyTOF panels

  • Enables simultaneous detection of 40+ proteins in single cells

  • Particularly valuable for mapping complex cellular hierarchies in testis

• Spatial transcriptomics correlation:

  • Combine CIB4 immunohistochemistry with spatial transcriptomics

  • Correlate protein localization with gene expression patterns

  • Create comprehensive spatial maps of CIB4 function in tissue context

• Super-resolution microscopy applications:

  • Apply STORM, PALM, or STED microscopy with CIB4 antibodies

  • Resolve subcellular localization at nanometer resolution

  • Examine protein clustering and co-localization at molecular scale

• Live-cell imaging approaches:

  • Develop cell-permeable CIB4 antibody fragments or nanobodies

  • Track dynamic protein behavior during spermatogenesis

  • Monitor calcium-dependent conformational changes in real-time

• Antibody-based proximity labeling:

  • Convert CIB4 antibodies to proximity labeling tools (APEX or TurboID fusion)

  • Map protein-protein interaction networks in specific cell types

  • Identify context-specific binding partners during spermatogenesis

• Single-cell proteomics integration:

  • Use CIB4 antibodies for single-cell Western blot or microfluidic proteomics

  • Correlate with single-cell RNA-seq data

  • Create multimodal profiles of individual cells during spermatogenesis

These technologies would significantly enhance our understanding of CIB4's role during the haploid phase of spermatogenesis, where it has been shown to be essential , by providing unprecedented resolution of its expression and function at the single-cell level.

How might CIB4 antibodies contribute to understanding the molecular basis of male contraceptive development?

CIB4 antibodies could play a pivotal role in male contraceptive research given CIB4's essential function in spermatogenesis:

• Target validation studies:

  • Use CIB4 antibodies to confirm expression in human testicular biopsies

  • Validate the timing of expression during spermatogenesis

  • Compare expression patterns between fertile and infertile men

• Mechanism elucidation:

  • Investigate how CIB4 regulates haploid spermatid development

  • Identify downstream pathways that could be targeted pharmaceutically

  • Map the structural basis of CIB4 interactions using epitope-specific antibodies

• Screening assay development:

  • Create cell-based screening systems with CIB4 antibodies as readouts

  • Develop high-throughput immunoassays to screen compound libraries

  • Establish in vitro models for rapid evaluation of CIB4-targeting approaches

• Preclinical model assessment:

  • Monitor CIB4 expression changes in response to candidate contraceptives

  • Correlate protein levels with functional outcomes in animal models

  • Identify optimal timing for intervention based on expression patterns

• Reversibility studies:

  • Use CIB4 antibodies to track protein recovery after contraceptive withdrawal

  • Monitor return to normal expression patterns during recovery

  • Identify any potential compensatory mechanisms

• Safety evaluation:

  • Examine CIB4 expression in non-target tissues to assess specificity

  • Investigate potential off-target effects of CIB4-directed interventions

  • Develop tissue-specific delivery approaches to minimize systemic exposure